Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Eyenovia Inc (EYEN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Eyenovia's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.010 +0.073    +7.74%
03/05 - Closed. Currency in USD ( Disclaimer )
After Hours
1.030
+0.020
+1.980%
19:19:31 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 2,469,971
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.950 - 1.140
Eyenovia 1.010 +0.073 +7.74%

Eyenovia Inc Company Profile

 
Get an in-depth profile of Eyenovia Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

44

Equity Type

ORD

Eyenovia, Inc. is a pre-commercial ophthalmic technology company. The Company is developing the Optejet delivery system both for use in combination with its own drug-device therapeutics and for out-licensing for use in combination with therapeutics for additional indications. Its product candidates include MicroLine (for presbyopia), MicroPine (for progressive myopia) and Mydcombi (for mydriasis). MicroLine is its microdosed version of pilocarpine, a well-understood ophthalmic medication that can dose-dependently induce miosis, or a contraction of the pupil. MicroPine is a topical treatment for progressive myopia, a back-of-the-eye disease. MicroPine program involves the development of a micro-formulation of atropine ophthalmic solution for reduction of myopia progression in children. Mydcombi is a fixed combination micro-formulation product candidate for mydriasis (eye dilation). Its fixed combination product candidate has been developed to facilitate efficient pupil dilation.

Contact Information

Address 295 Madison Avenue Suite 2400
New York, 10017
United States
Phone 917 289 1117
Fax -

Top Executives

Name Age Since Title
Michael M. Rowe 60 2018 CEO & Director
Tsontcho Ianchulev 48 2014 Co-Founder, President, Chief Medical Officer & Non-Executive Chairman
Charles E. Mather 62 2018 Independent Director
Ram Palanki - 2022 Independent Director
James C. Tsai - - Member of Scientific Advisory Board
Louis R. Pasquale - - Member of Scientific Advisory Board
Douglas Fredrick - - Member of Scientific Advisory Board
April Jasper - 2019 Member of Scientific Advisory Board
Shan Lin - - Member of Scientific Advisory Board
Robert N. Weinreb - - Member of Scientific Advisory Board
Rachel Jacobson 48 2022 Independent Director
Stephen K. Benjamin 52 2022 Independent Director
Pamela F. Gallin - - Member of Scientific Advisory Board
Mark Bullimore - 2019 Member of Scientific Advisory Board
Ellen R. Strahlman 65 2022 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

EYEN Comments

Write your thoughts about Eyenovia Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Avise Analytics
Avise Sep 01, 2021 8:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.reddit.com/r/MicrocapStocksRun/comments/pfs8ib/5_biotech_stocks_insiders_are_buying/?utm_source=share&utm_medium=web2x&context=3
robert todino
robert todino Aug 11, 2020 10:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I hate pump and dumps like this which pull back, start to go back up and then drop like a rock once your in!
Lake Lot
Lake Lot Feb 08, 2019 6:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bought at 10 with director trading , happy to get out at 6 . Will rebuy at 2.50 soon .
MfB Iod
MfB Iod Feb 08, 2019 6:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
so you sold at a loss?
Gershom Zvi
Gershom Zvi Feb 08, 2019 6:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It cost $10 only in the very beginning in Janury 2018 so you got this stock as salary package, right ?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email